LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

Inicio・Lista de Acciones・Globus Medical Inc (Class A)

Globus Medical Inc (Class A)

Cerrado

Sector Salud

74.97 1.68

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

74.7

Máximo

75.28

Métricas clave
By Trading Economics
Ingresos	39M 32M
Ventas	23M 630M
P/B Media del Sector	126.83 104.138
BPA	0.75
Margen de beneficio	5.044
Empleados	5,000
EBITDA	43M 128M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 meses	+6.28 upside

Dividendos
By Dow Jones
Próximas Ganancias	5 nov 2024

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	56M 10B
Apertura anterior	73.29
Cierre anterior	74.97

Noticias sobre sentimiento de mercado

By Acuity

50%

167 / 389 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

73.49 / 75.07 Soporte y Resistencia

Globus Medical Inc (Class A) Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

1 nov 2024, 22:50 UTC

Acciones populares

Stocks to Watch: Nvidia, Intel, Sherwin-Williams, Dow, Nuwellis

1 nov 2024, 22:43 UTC

Principales Movimientos del Mercado

Nvidia, Sherwin-Williams Shares Up on Addition to DJIA

1 nov 2024, 22:13 UTC

Principales Movimientos del Mercado

Chewy Up 5% on S&P MidCap 400 Inclusion

1 nov 2024, 21:39 UTC

Ganancias

Insurance Company Chubb Projects Up to $300 Million Pre-Tax Loss on Hurricane

2 nov 2024, 13:53 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- Update

2 nov 2024, 13:44 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2 nov 2024, 13:00 UTC

Ganancias

China's EV Makers Set Sights on Latin America in Global Expansion -- WSJ

2 nov 2024, 12:58 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2 nov 2024, 12:48 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- WSJ

2 nov 2024, 12:32 UTC

Ganancias

Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com

2 nov 2024, 12:28 UTC

Adquisiciones, fusiones, absorciones

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2 nov 2024, 12:17 UTC

Ganancias

Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com

2 nov 2024, 12:00 UTC

Ganancias

Berkshire Hathaway 3Q EPS $18272.00 >BRKA

2 nov 2024, 12:00 UTC

Ganancias

Berkshire Hathaway 3Q BNSF Operating Earnings $1.38B >BRKA

2 nov 2024, 12:00 UTC

Ganancias

Berkshire Hathaway 3Q Berkshire Hathaway Energy Company Operating Earnings $1.63B >BRKA

2 nov 2024, 12:00 UTC

Ganancias

Berkshire Hathaway 3Q Insurance-Underwriting Operating Earnings $750M >BRKA

2 nov 2024, 12:00 UTC

Ganancias

Berkshire Hathaway 3Q Other Operating Loss $877M >BRKA

2 nov 2024, 12:00 UTC

Ganancias

Berkshire Hathaway 3Q Insurance-Investment Income Operating Earnings $3.66B >BRKA

2 nov 2024, 12:00 UTC

Ganancias

Berkshire Hathaway 3Q Net $26.25B >BRKA

2 nov 2024, 12:00 UTC

Ganancias

Berkshire Hathaway 3Q Other Controlled Businesses Operating Earnings $3.34B >BRKA

2 nov 2024, 12:00 UTC

Ganancias

Berkshire Hathaway 3Q Non-Controlled Businesses Operating Earnings $199M >BRKA

2 nov 2024, 12:00 UTC

Ganancias

Berkshire Hathaway 3Q Operating Earnings $10.09B >BRKA

2 nov 2024, 12:00 UTC

Ganancias

Berkshire Hathaway 3Q Investment, Derivative Gains $16.16B >BRKA

2 nov 2024, 09:30 UTC

Principales Noticias

Awful Jobs Report Aside, the Economy Is Still Strong -- Heard on the Street -- WSJ

2 nov 2024, 08:20 UTC

Charlas de Mercado

Ganancias

Tech, Media & Telecom Roundup: Market Talk

2 nov 2024, 08:20 UTC

Charlas de Mercado

Ganancias

Auto & Transport Roundup: Market Talk

1 nov 2024, 22:51 UTC

Ganancias

Correction to Nvidia to Replace Intel in Dow Jones Industrial Average Article -- WSJ

1 nov 2024, 22:00 UTC

Principales Noticias

Ganancias

Nvidia to Replace Intel in Dow Jones Industrial Average. Sherwin-Williams Also Joins. -- WSJ

1 nov 2024, 21:29 UTC

Principales Noticias

Ganancias

Exxon and Chevron Feel Brunt of Cheaper Oil -- 2nd Update

1 nov 2024, 21:24 UTC

Ganancias

Insurance Company Chubb Projects Up to $300M Pre-Tax Loss on Hurricane

Comparación entre iguales

Cambio de precio

Globus Medical Inc (Class A) Esperado

Precio Objetivo

By TipRanks

6.28% repunte

Estimación a 12 meses

Media 79.58 USD 6.28%

Máximo 100 USD

Mínimo 55 USD

De acuerdo con 15 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Globus Medical Inc (Class A) Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

15 ratings

Comprar

Mantener

Vender

De acuerdo con 15 analistas que ofrecen calificaciones bursátiles a para Globus Medical Inc (Class A) Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

73.49 / 75.07Soporte y Resistencia

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Bullish events outweigh bearish events.

Sentimiento

By Acuity

167 / 389 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

EBITDA

Beneficio operativo

Acerca de Globus Medical Inc (Class A)

Globus Medical, Inc. is a medical device company. The Company is primarily focused on implants that promote healing in patients with musculoskeletal disorders. The Company group its products into two categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in an expansive range of spinal, orthopedic and neurosurgical procedures. Its Enabling Technologies are comprised of imaging, navigation and robotics (INR) solutions for assisted surgery, which are computer-assisted intelligent systems designed to improve a surgeon’s capabilities, and ultimately improve patient care and reduce radiation exposure for all involved. Its INR solutions include the ExcelsiusGPS platform, which is a robotic guidance and navigation system that supports minimally invasive and open procedures with screw and interbody spacer placement applications.